We are trying to differentiate primary human monocytes from 30 ml of peripheral blood into monocyte-derived macrophages for differentiation studies.
However, we are losing cell viability quite drastically and end up with not enough cells to run experiments.
Following PBMC isolation - using Ficoll and negative selection with Miltenyi monocyte isolation kit II - we allow PBMCs to adhere to TC-treated 24-well plates (8x105 per well) containing 1 ml of RPMI-1640 supplemented with pen/strep 1% (v/v), 10% FBS and M-CSF (20ng/ml).
After a media change on day 3, we harvest cells at day 7 using Accutase. Although PBMCs adhere on the day of isolation and look beautiful on the first few days, they are often loosely-adherent and loose viability after day 4.
We typically obtain 3,5x107 PBMCs after isolation, 4,5x106 cells following magnetic separation and harvest 8x105 monocyte-derived macrophages at day 7. Most of these cells collected at day 7 are already dead (cellular yield around 18%). I would have to further differentiate these cells into M1, M2 at this point, but so far I have been unable to obtain a reasonable cell count.
Any suggestions on how to avoid these problems? Maybe the concentration of M-CSF, non TC plates, humam serum?
Shall I use tissue culture treated polystyrene plates or non-tissue culture treated ones? Any particular recommendation?
Does it make a difference using human serum from AB clotted whole blood or AB plasma?